|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 512 10TH STREET NW |
Address2 | |
City | WASHINGTON |
State | DC |
Zip Code | 20004 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 28481-12
|
||||||||
|
6. House ID# 316440000
|
TYPE OF REPORT | 8. Year | 2009 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Douglas Johnson, Legislative Director |
Date | 10/16/2009 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Contacts to House and Senate offices in support of continuation of traditional prolife provisions in appropriations bills for fiscal year 2010, including Hyde Amendment to HHS appropriations bill (H.R. 3293). Supported Pence Amendment to H.R. 3293 (to remove Title X PHSA funds from Planned Parenthood) (failed July 24, 2009). Supported Tiahrt-Davis Amendment to H.R. 3170 (Financial Services appropriations) to retain traditional ban on use of congressionally appropriated funds for elective (continued)
abortion in the District of Columbia (failed in Appropriations Committee, July 7); opposed H.R. 3170 on House floor on July 16, 2009, because of new language allowing use of congressionally appropriated funds for elective abortion in the District of Columbia. In the Senate Appropriations Committee, supported Brownback Amendment to S. 1432 (Financial Services appropriations) to retain/restore traditional language prohibiting use of congressionally appropriated funds for elective abortion in the District of Columbia (failed on July 9); opposed S. 1432 as reported due to inclusion of language that would allow use of congressionally appropriated funds for elective abortion in the District of Columbia, and because of deletion of longstanding provision barring coverage of elective abortions under the Federal Employees Health Benefits (FEHB) program.
In Senate Appropriations Committee, opposed Lautenberg Amendment to S. 1434 (State-Foreign Operations Appropriations bill), to permanently prohibit any president from restricting funding of organizations that promote abortion in foreign nations (adopted July 9); opposed S. 1434 as reported due to inclusion of the Lautenberg Amendment.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Douglas |
Johnson |
|
|
|
Susan |
Muskett |
|
|
|
Andrea |
Lyon |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FAM
16. Specific lobbying issues
Contacts with House and Senate in opposition to the "Freedom of Choice Act" (FOCA), a bill to invalidate virtually all state and federal laws and policies that in any way limit access to abortion, the reintroduction of which is anticipated sometime during the 111th Congress. (continued)
Contacts to House in support of Child Interstate Abortion Notification Act (CIANA) (H.R. 634) and the Child Custody Protection Act (unnumbered).
Contacts in support of S. 85 and H.R. 614, and the Pence Amendment to H.R. 3293, all measures to exclude certain abortion providers from funding under Title X of the Public Health Service Act.
Contacts in support of H.R. 636, the Positive Alternatives Act, sponsored by Rep. Michele Bachmann.
Contacts generally supportive of certain titles of S. 270 and H.R. 605, Pregnant Women and Family Support Act, while not taking a position on the overall omnibus legislation at this time. Contacts expressing objections to certain components of S. 21 and H.R. 463. Contacts critiquing numerous deficiencies in Ryan-DeLauro bill (H.R. 3293).
Contacts in support of H.R. 649, the Ultrasound Informed Consent Act; H.R. 213, the Adoption Tax Relief Guarantee Act; and H.R. 195, the Informed Choice Act (aid for ultrasound machines for certain centers).
Consultations regarding legislation to protect conscience rights of health-care providers with respect to abortion, and contacts in support of Coburn Amendment No. 828 to the Senate budget resolution, S. Con. Res. 13.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Douglas |
Johnson |
|
|
|
Susan |
Muskett |
|
|
|
Andrea |
Lyon |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FOR
16. Specific lobbying issues
Opposed to Lautenberg Amendment to S. 1434 (State-Foreign Operations appropriations), adopted in Senate Appropriations Committee on July 9, 2009 (amendment would permanently prohibit a president from steering funds away from groups that perform
and actively promote abortion as a method of family planning); opposed to S. 1434 due to addition of the Lautenberg Amendment.(continued)
Contacts to House expressing general concerns about abortion-related issues that may arise during anticipated reauthorization/rewrite of the Foreign Assistance Act.
Contacts in opposition the Senate radification of the Convention for the Elimination of All Forms of Discrimination Against Women (CEDAW) and in opposition to H. Res. 22, a pro-CEDAW resolution.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Douglas |
Johnson |
|
|
|
Susan |
Muskett |
|
|
|
Andrea |
Lyon |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Contacts in support of amendments to remove pro-abortion mandates and abortion subsidies from all health care reform bills. Includes contracts in support of Enzi, Hatch, and Coburn pro-life amendments to the "Affordable Health Choices Act" (later designated as S. 1679), contacts in support of Hatch pro-life amendments to the "America's Healthy Future Act" (continued)
considered in the Senate Finance Committee; support for Stupak-Pitts Amendment and other pro-life amendments offered to H.R. 3200 in the House committees on Energy and Commerce, Education and Labor, and Ways and Means. Contacts in opposition to pro-abortion Capps-Waxman Amendment added to H.R. 3200 in Energy and Commerce Committee. Opposed to all three bills due to rejection of the pro-life amendments, and because of other objectionable provisions enumerated on subsequent pages.
Also on "Affordable Health Choices Act," contacts: in support of amendment to prevent abortion clnics from receiving FQHC grants; in opposition to Kennedy phony conscience-protection amendment; providing analysis of Mikulski Amendment pertaining to essential community providers. Also on "America's Healthy Future Act," analysis of Stabenow Amendment C-5.
Contacts to House members to encourage signing of letter from Rep. Stupak, et al, to Speaker Pelosi, seeking opportunity for House to vote on Stupak-Pitts Amendment to neutralize provisions of H.R. 3200 that would result in direct government funding of abortion under a federal "public plan" and federal premium subsidies for private insurance plans that would cover elective abortion (sent September 28, 2009).
Analysis of H.R. 3400, Empowering Patients First Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Douglas |
Johnson |
|
|
|
Susan |
Muskett |
|
|
|
Andrea |
Lyon |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
On the Senate Finance Committees Chairmans Mark, Americas Healthy Future Act of 2009, contacts in support of addition of variable withhold financing method to avoid rationing. Contacts in support of the Chairmans mark anti-discrimination language as it related to Comparative Effectiveness Research. (continued)
Contacts in support of extending the comparative effectiveness style anti-discrimination language to other portions of the mark. Contacts in support of Sen. Kyl amendment D2-125 and Sen. Roberts amendment D1-137 which would eliminate the 5% penalty for Medicare physicians in the top 10% of spending. Contacts in support of Kyl amendment 152 which would allow senior citizens to opt out of Medicare. Contacts to oppose Rockefeller amendments 207, 208, and 210, relating to advance care planning because: contains disincentive for balanced counseling and incentives to steer them toward rejection of treatment, including life-preserving treatment, lacks representatives of disability rights groups and groups who advocate for treatment without regard to patients quality of life, lacks continuing oversight and evaluation of created board, lacks protections for portability of advanced directives across states, lacked conscience protections, and made changes to Assisted Suicide Funding Restriction Act of 1997. Contacts to support Bunning Amendment D3-135 or Bunning Amendment D1-130 to require a Congressional vote in order to implement recommendations of the Medicare Commission.
On S.1679, the Affordable Health Choices Act, contacts in support of the addition of variable withhold financing method to avoid rationing. Contacts in support of Enzi Amendment 210 to prohibit the community health insurance option from denying patients medical care needed to prevent their deaths or preserve or restore their health. Contacts in support of Enzi Amendment 271 to prohibit regulation that preclude plan or issuer from providing payment for a treatment or diagnostic procedure it chooses to cover, unless such treatment or procedure has been determined to be unsafe or dangerous. Contacts in support of Enzi Amendment 272 to prevent denial of care based on patient age, disability, medical dependency or quality of life. Contacts in support of Enzi Amendment 273 to prohibit regulations that preclude providers from providing or prescribing any treatment or diagnostic procedure that has not been determined to be unsafe or dangerous. Contacts in support of Enzi Amendment 274 to prohibit the Exchange from excluding qualified plans by: using premium price controls, excluding fee-for-service plans, or requiring plans to deny policyholders life-saving medical treatment. Contacts in support of Enzi Amendment 279 which would preserve the option of fee-for-service healthcare. Contacts in support of Enzi Amendment 280 which would prevent the denial of end of life care and which would prohibit the Exchange from excluding plans that choose not to limit access to therapies and treatment. Contacts in support of Enzi Amendment 283 which would prohibit the Secretary of Health and Human Services from setting payment rates for items and services that are medically necessary. Contacts in support of Enzi Amendment 284 which would prohibit the Secretary of Health and Human Services from limiting access to any therapies or treatments that are medically necessary. Contacts in support of Enzi Amendment 285 to prohibit the Secretary of Health and Human Services from limiting access to end of life care by allowing the public option to employ a pattern or practice of discrimination based on the age, disability or purported "quality of life" of the patient. Contacts regarding Sen. Hatch amendment 229 to ensure that taxpayer funds do not support or fund physician assisted suicide. Contacts regarding Sen. Coburn Amendment 237 that would ensure healthcare providers are not forced to participate in assisted suicide or discriminated against because they choose not to participate in assisted suicide. Contacts regarding Sen. Coburn amendment 220 for general conscience protection and protection against discrimination.
On S. 1213, The Patient-Centered Outcomes Research Act of 2009, regarding comparative effectiveness standards in Medicare, worked to ensure that patients competence, age, expected length of life, present or predicted disability, degree of medical dependency, or quality of life will not be used as the basis for denial of Medicare benefits to patients against their wishes.
On S. 1133, Empowering Medicare Patient Choices Act, supported the removal of language which creates an unacceptable disincentive for balanced counseling and assistance that genuinely attempts to elucidate patients values and preferences, and an incentive to steer them toward rejection of treatment, including life-preserving treatment. Urged the inclusion on advisory council of representatives of disability rights groups and groups who advocate for treatment without regard to patients quality of life.
On S.1263 Senior Navigation and Planning Act of 2009, supported the removal of language which creates an unacceptable disincentive for balanced counseling and assistance that genuinely attempts to elucidate patients values and preferences, and an incentive to steer them toward rejection of treatment, including life-preserving treatment. Urged the inclusion on advisory board of representatives of disability rights groups and groups who advocate for treatment without regard to patients quality of life. Urged continuing oversight and evaluation by created board. Urged changes to provisions regarding portability of advanced directives across states. Urged the inclusion of conscience protections. (continued)
On Senate 1150 Advance Planning and Compassionate Care Act of 2009, urged that a qualified oversight body make recommendations concerning various informational elements of the legislation. Opposed provision that would repeal provisions of the Assisted Suicide Funding Restriction Act. Sought the inclusion of protective language that would safeguard state modifications when they had adopted the Uniformed Health Care Decisions Act.
On health care reform generally, contacts in effort to oppose rationing of health care and support the addition of variable withhold financing method to avoid rationing.
U.S. House of Representatives
On H.R. 3200, America's Affordable Health Choices Act of 2009, contacts in support of language to exclude rationing of health care. Contacts in support of language to prevent comparative effectiveness research from being used in making coverage decisions, determining reimbursement rates, or establishing incentive programs in ways that discriminatorily deny or limit health care based on age, present or predicted disability, or expected length of life. Contacts in support of prohibition of using quality adjusted life years (or other standards that discount the value of a period of life based on the patients present or predicted disability or quality of life) being employed in making coverage decisions, determining reimbursement rates, or establishing incentive programs. Contacts in support of the inclusion of Comparative Effectiveness panel members that represent disability rights organizations as well as represent organizations that advocate for the rights of patients to obtain treatment without regard to the patients quality of life. Contacts in support of prohibiting Commissioner from terminating qualified plans by: using premium price controls, excluding fee-for-service plans, or requiring plans to deny policyholders life-saving medical treatment. Contacts in support of prohibiting the Commissioner from implementing premium price controls. Contacts to support striking a section that would incent Medicare providers to limit treatment utilization. Contacts to support language that would ensure that neither the Exchange or the public insurance option employ a pattern or practice of discrimination based on the age, disability or purported "quality of life" of the patient. Contacts to support language to ensure that health benefits established as essential not be subject to denial to patients against their wishes on the basis of patients' age or expected length of life or of patients' present or predicted disability, degree of medical dependency, or quality of life. Contacts to support language that no health plan or health insurance issuer shall be forced to deny patients medical care needed to prevent their deaths or preserve or restore their health and no plan or issuer shall be prohibited from providing a treatment or diagnostic procedure it chooses to cover, unless such treatment or procedure has been determined to be unsafe, dangerous, or capable neither of preventing the patient's death nor of preserving or restoring the patient's health.
On health care reform generally, contacts in effort to oppose rationing of health care and support the addition of variable withhold financing method to avoid rationing.
Executive Office of the President
U.S. Senate
Contacts in support of introduction of language into the Senate Finance Committees Chairmans Mark, Americas Healthy Future Act of 2009, to prevent comparative effectiveness research from being used in making coverage decisions, determining reimbursement rates, or establishing incentive programs in ways that discriminatorily deny or limit health care based on age, present or predicted disability, or expected length of life. Contacts in support of prohibition of using quality adjusted life years (or other standards that discount the value of a period of life based on the patients present or predicted disability or quality of life) being employed in making coverage decisions, determining reimbursement rates, or establishing incentive programs.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Executive Office of the President (EOP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Thomas (Burke) |
Balch |
|
|
|
Jennifer |
Popik |
|
|
|
Susan |
Muskett |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code INS
16. Specific lobbying issues
Contacts in support of exclusion of amendments to remove pro-abortion mandates and abortion subsidies from all health care reform bills. Includes contacts in support of Enzi, Hatch, and Coburn pro-life amendments to the "Affordable Health Choices Act" (later designated as S. 1679), contacts in support of Hatch pro-life amendments to the "America's Healthy Future Act" (continued)
considered in the Senate Finance Committee; support for Stupak-Pitts Amendment and other pro-life amendments offered to H.R. 3200 in the House committees on Energy and Commerce, Education and Labor, and Ways and Means. Contacts in opposition to pro-abortion Capps-Waxman Amendment added to H.R. 3200 in Energy and Commerce Committee. Opposed to all three bills due to rejection of the pro-life amendments, and because of other objectionable provisions enumerated on other pages.
Contacts to House members to encourage signing of letter from Rep. Stupak, et al, to Speaker Pelosi, seeking opportunity for House to vote on Stupak-Pitts Amendment to neutralize provisions of H.R. 3200 that would result in direct government funding of abortion under a federal "public plan" and federal premium subsidies for private insurance plans that would cover elective abortion (sent September 28, 2009).
Analysis of H.R. 3400, Empowering Patients First Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Douglas |
Johnson |
|
|
|
Susan |
Muskett |
|
|
|
Andrea |
Lyon |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
Contacts in opposition to anticipated authorization legislation to allow or require federal funding of research that requires killing of human embryos and/or creation of human embryos by cloning, and urging continuation of Dickey-Wicker embryo-protection language on FY 2010 appropriations bill for Labor-HHS. (continued)
Contacts in support of H.R. 877, Patients First Act, sponsored by Reps. Forbes and Lipinski (to promote federal funding of ethical forms of stem cell research), and H.R. 1050, the Human Cloning Prohibition Act, sponsored by Reps. Bart Stupak and Zach Wamp, to prohibit the creation of embryos of the species homo sapiens by cloning.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Douglas |
Johnson |
|
|
|
Susan |
Muskett |
|
|
|
Andrea |
Lyon |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
U.S. Senate
On the Senate Finance Committees Chairmans Mark, Americas Healthy Future Act of 2009, contacts in support of addition of variable withhold financing method to avoid rationing. Contacts in support of the Chairmans mark anti-discrimination language as it related to Comparative Effectiveness Research. (continued)
Contacts in support of extending the comparative effectiveness style anti-discrimination language to other portions of the mark. Contacts in support of Sen. Kyl amendment D2-125 and Sen. Roberts amendment D1-137 which would eliminate the 5% penalty for Medicare physicians in the top 10% of spending. Contacts in support of Kyl amendment 152 which would allow senior citizens to opt out of Medicare. Contacts to oppose Rockefeller amendments 207, 208, and 210, relating to advance care planning because: contains disincentive for balanced counseling and incentives to steer them toward rejection of treatment, including life-preserving treatment, lacks representatives of disability rights groups and groups who advocate for treatment without regard to patients quality of life, lacks continuing oversight and evaluation of created board, lacks protections for portability of advanced directives across states, lacked conscience protections, and made changes to Assisted Suicide Funding Restriction Act of 1997. Contacts to support Bunning Amendment D3-135 or Bunning Amendment D1-130 to require a Congressional vote in order to implement recommendations of the Medicare Commission.
On S.1679, the Affordable Health Choices Act, contacts in support of the addition of variable withhold financing method to avoid rationing. Contacts in support of Enzi Amendment 210 to prohibit the community health insurance option from denying patients medical care needed to prevent their deaths or preserve or restore their health. Contacts in support of Enzi Amendment 271 to prohibit regulation that preclude plan or issuer from providing payment for a treatment or diagnostic procedure it chooses to cover, unless such treatment or procedure has been determined to be unsafe or dangerous. Contacts in support of Enzi Amendment 272 to prevent denial of care based on patient age, disability, medical dependency or quality of life. Contacts in support of Enzi Amendment 273 to prohibit regulations that preclude providers from providing or prescribing any treatment or diagnostic procedure that has not been determined to be unsafe or dangerous. Contacts in support of Enzi Amendment 274 to prohibit the Exchange from excluding qualified plans by: using premium price controls, excluding fee-for-service plans, or requiring plans to deny policyholders life-saving medical treatment. Contacts in support of Enzi Amendment 279 which would preserve the option of fee-for-service healthcare. Contacts in support of Enzi Amendment 280 which would prevent the denial of end of life care and which would prohibit the Exchange from excluding plans that choose not to limit access to therapies and treatment. Contacts in support of Enzi Amendment 283 which would prohibit the Secretary of Health and Human Services from setting payment rates for items and services that are medically necessary. Contacts in support of Enzi Amendment 284 which would prohibit the Secretary of Health and Human Services from limiting access to any therapies or treatments that are medically necessary. Contacts in support of Enzi Amendment 285 to prohibit the Secretary of Health and Human Services from limiting access to end of life care by allowing the public option to employ a pattern or practice of discrimination based on the age, disability or purported "quality of life" of the patient. Contacts regarding Sen. Hatch amendment 229 to ensure that taxpayer funds do not support or fund physician assisted suicide. Contacts regarding Sen. Coburn Amendment 237 that would ensure healthcare providers are not forced to participate in assisted suicide or discriminated against because they choose not to participate in assisted suicide. Contacts regarding Sen. Coburn amendment 220 for general conscience protection and protection against discrimination.
On S. 1213, The Patient-Centered Outcomes Research Act of 2009, regarding comparative effectiveness standards in Medicare, worked to ensure that patients competence, age, expected length of life, present or predicted disability, degree of medical dependency, or quality of life will not be used as the basis for denial of Medicare benefits to patients against their wishes.
On S. 1133, Empowering Medicare Patient Choices Act, supported the removal of language which creates an unacceptable disincentive for balanced counseling and assistance that genuinely attempts to elucidate patients values and preferences, and an incentive to steer them toward rejection of treatment, including life-preserving treatment. Urged the inclusion on advisory council of representatives of disability rights groups and groups who advocate for treatment without regard to patients quality of life.
On S.1263 Senior Navigation and Planning Act of 2009, supported the removal of language which creates an unacceptable disincentive for balanced counseling and assistance that genuinely attempts to elucidate patients values and preferences, and an incentive to steer them toward rejection of treatment, including life-preserving treatment. Urged the inclusion on advisory board of representatives of disability rights groups and groups who advocate for treatment without regard to patients quality of life. Urged continuing oversight and evaluation by created board. Urged changes to provisions regarding portability of advanced directives across states. Urged the inclusion of conscience protections.
On Senate 1150 Advance Planning and Compassionate Care Act of 2009, urged that a qualified oversight body make recommendations concerning various informational elements of the legislation. Opposed provision that would repeal provisions of the Assisted Suicide Funding Restriction Act. Sought the inclusion of protective language that would safeguard state modifications when they had adopted the Uniformed Health Care Decisions Act.
On health care reform generally, contacts in effort to oppose rationing of health care and support the addition of variable withhold financing method to avoid rationing.
U.S. House of Representatives
On H.R. 3200, America's Affordable Health Choices Act of 2009, contacts in support of language to exclude rationing of health care. Contacts in support of language to prevent comparative effectiveness research from being used in making coverage decisions, determining reimbursement rates, or establishing incentive programs in ways that discriminatorily deny or limit health care based on age, present or predicted disability, or expected length of life. Contacts in support of prohibition of using quality adjusted life years (or other standards that discount the value of a period of life based on the patients present or predicted disability or quality of life) being employed in making coverage decisions, determining reimbursement rates, or establishing incentive programs. Contacts in support of the inclusion of Comparative Effectiveness panel members that represent disability rights organizations as well as represent organizations that advocate for the rights of patients to obtain treatment without regard to the patients quality of life. Contacts in support of prohibiting Commissioner from terminating qualified plans by: using premium price controls, excluding fee-for-service plans, or requiring plans to deny policyholders life-saving medical treatment. Contacts in support of prohibiting the Commissioner from implementing premium price controls. Contacts to support striking a section that would incent Medicare providers to limit treatment utilization. Contacts to support language that would ensure that neither the Exchange or the public insurance option employ a pattern or practice of discrimination based on the age, disability or purported "quality of life" of the patient. Contacts to support language to ensure that health benefits established as essential not be subject to denial to patients against their wishes on the basis of patients' age or expected length of life or of patients' present or predicted disability, degree of medical dependency, or quality of life. Contacts to support language that no health plan or health insurance issuer shall be forced to deny patients medical care needed to prevent their deaths or preserve or restore their health and no plan or issuer shall be prohibited from providing a treatment or diagnostic procedure it chooses to cover, unless such treatment or procedure has been determined to be unsafe, dangerous, or capable neither of preventing the patient's death nor of preserving or restoring the patient's health.
On health care reform generally, contacts in effort to oppose rationing of health care and support the addition of variable withhold financing method to avoid rationing.
Executive Office of the President
U.S. Senate
Contacts in support of introduction of language into the Senate Finance Committees Chairmans Mark, Americas Healthy Future Act of 2009, to prevent comparative effectiveness research from being used in making coverage decisions, determining reimbursement rates, or establishing incentive programs in ways that discriminatorily deny or limit health care based on age, present or predicted disability, or expected length of life. Contacts in support of prohibition of using quality adjusted life years (or other standards that discount the value of a period of life based on the patients present or predicted disability or quality of life) being employed in making coverage decisions, determining reimbursement rates, or establishing incentive programs.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Executive Office of the President (EOP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Thomas (Burke) |
Balch |
|
|
|
Jennifer |
Popik |
|
|
|
Susan |
Muskett |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code SCI
16. Specific lobbying issues
Contacts in opposition to anticipated authorization legislation to allow or require federal funding of research that requires killing of human embryos and/or creation of human embryos by cloning, and urging continuation of Dickey-Wicker embryo-protection language on FY 2010 appropriations bill for Labor-HHS. (continued)
Contacts in support of H.R. 877, Patients First Act, sponsored by Reps. Forbes and Lipinski (to promote federal funding of ethical forms of stem cell research), and H.R. 1050, the Human Cloning Prohibition Act, sponsored by Reps. Bart Stupak and Zach Wamp, to prohibit the creation of embryos of the species homo sapiens by cloning.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Douglas |
Johnson |
|
|
|
Susan |
Muskett |
|
|
|
Andrea |
Lyon |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code GOV
16. Specific lobbying issues
Contacts in opposition to confirmation of Dawn Johnsen as assistant attorney general for the Office of Legal Counsel. Contacts in opposition to confirmation of Judge Sonia Sotomayor as associate justice of the U.S. Supreme Court (including letter dated July 27, 2009).
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Douglas |
Johnson |
|
|
|
Susan |
Muskett |
|
|
|
Andrea |
Lyon |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DOC
16. Specific lobbying issues
On Financial Services appropriations bill (H.R. 3170), supported Tiahrt-Davis Amendment to continue longstanding ban on the use of congressionally appropriated funds to pay for elective abortion in the District of Columbia (amendment failed in Appropriations Committee, July 7); opposed H.R. 3170 on House floor on July 16, 2009, because of new language allowing use of congressionally appropriated funds for elective abortion in the District of Columbia. (continued)
In the Senate Appropriations Committee, supported Brownback Amendment to S. 1432 (Financial Services appropriations) to retain/restore traditional language prohibiting use of congressionally appropriated funds for elective abortion in the District of Columbia (failed on July 9); opposed S. 1432 as reported due to inclusion of the language that would allow use of congressionally appropriated funds for elective abortion in the District of Columbia.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Douglas |
Johnson |
|
|
|
Susan |
Muskett |
|
|
|
Andrea |
Lyon |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Opposition to Grassley Amendments F7 and F8 to "America's Healthy Future Act" (as yet unnumbered) in Senate Finance Committee.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Susan |
Muskett |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
5 |
|
||||||
2 |
|
6 |
|
||||||
3 |
|
7 |
|
||||||
4 |
|
8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
CIV |
|
|
|
|
|
|
|
|
COM |
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 3 | 5 |
2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 5 | 9 |
2 | 6 | 10 |
3 | 7 | 11 |
4 | 8 | 12 |